2007
DOI: 10.1007/s00467-007-0520-4
|View full text |Cite
|
Sign up to set email alerts
|

Reno-vascular hypertension in childhood: a nationwide survey

Abstract: Renovascular disease accounts for 8-10% of all cases of paediatric hypertension, whereas, in adults, its incidence is approximately 1%. The Turkish Paediatric Hypertension Group aimed to create the first registry database for childhood renovascular hypertension in Turkey. Twenty of the 28 paediatric nephrology centres in Turkey responded to the survey and reported 45 patients (27 girls, 18 boys) with renovascular hypertension between 1990 and 2005. The age at presentation ranged from 20 days to 17 years. The m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
35
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(36 citation statements)
references
References 34 publications
0
35
0
1
Order By: Relevance
“…In pediatrics, FMD is reported to be the most important cause of renovascular hypertension, but the prevalence is not precisely known. In a cohort of Turkish children with renovascular hypertension, FMD was found in 31% (5).…”
Section: Introductionmentioning
confidence: 99%
“…In pediatrics, FMD is reported to be the most important cause of renovascular hypertension, but the prevalence is not precisely known. In a cohort of Turkish children with renovascular hypertension, FMD was found in 31% (5).…”
Section: Introductionmentioning
confidence: 99%
“…Early diagnosis is essential because adequate treatment can prevent target organ damage 3 5. In the case described, RVH diagnosis was late and difficult because of its presentation with FTT, slowing of linear growth and atypical neurological signs.…”
Section: Discussionmentioning
confidence: 99%
“…Hence a stepwise reduction should be planned. Hypertensive emergencies should be treated by an IV antihypertensive that can produce a controlled reduction in the BP, aiming to decrease the pressure by 25% over the first 8 hours after presentation and then gradually normalizing the BP over the next 48 hours 7 . IV labetalol and sodium nitroprusside are the preferred agents.…”
Section: Discussionmentioning
confidence: 99%